Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Optimal corticosteroid dosing for ARDS: short vs. prolonged therapy

Official title: Corticosteroids for Acute Respiratory Distress Syndrome: A Proof-of-Concept Trial Exploring Biological Heterogeneity and Treatment Response

Run by National Taiwan University Hospital · NCT07711964 · Data updated 2026-11-12

This trial tests different corticosteroid doses and treatment lengths to see which helps adults with ARDS who are on ventilators.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedJune 15, 2025
Main results expectedApril 30, 2030
Study endsJune 30, 2030
Registry record updatedJuly 17, 2026
Trial IDNCT07711964 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Berlin-defined ARDS requiring invasive mechanical ventilation and not already on systemic steroids, with intubation less than 3 days.

Probably not a fit

Patients who do not respond to corticosteroids or who have contraindications to steroid therapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 3-by-2 factorial interventional trial in adults with ARDS to compare no steroids, low-dose regimens, and a medium-dose regimen, each given for 7 or 10 days. The study focuses on identifying how dose and duration of corticosteroids influence outcomes in early ARDS. Participants must be intubated for ARDS and not already on systemic steroids. The trial is led by National Taiwan University Hospital and conducted at a single center in Taipei.

Why it matters

Potential benefit: If successful, the study could clarify optimal corticosteroid dosing and duration to improve recovery and survival in ARDS.

How similar studies have gone: Previous trials suggest corticosteroids can help in related respiratory conditions, but head-to-head ARDS dose-duration comparisons are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ARDS (as defined by the Berlin definition) with an FiO₂ of 0.5 or higher
* On invasive mechanical ventilation
* Duration of intubation less than three days

Exclusion Criteria:

* Age less than 18 years
* Required to receive steroids or considered ineligible for steroids by the primary care team
* Receiving systemic steroid therapy
* Uncontrolled gastrointestinal bleeding
* Uncontrolled infeciotn

Where it's running

  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.